Location: Children's Nutrition Research Center
Title: Haploinsufficiency of CYP8B1 associates with increased insulin sensitivity in humansAuthor
ZHONG, SHIQI - National University Of Singapore | |
CHEVRE, RAPHAEL - Singapore Immunology Network (SIGN), Agency For Science, Technology And Research | |
CASTANO MAYAN, DAVID - National University Of Singapore | |
CORLIANO, MARIA - National University Of Singapore | |
COCHRAN, BLAKE - University Of New South Wales | |
PING SEM, KAI - Singapore Immunology Network (SIGN), Agency For Science, Technology And Research | |
VAN DIJIK, THEO - University Of Groningen | |
PENG, JIANHE - Singapore Immunology Network (SIGN), Agency For Science, Technology And Research | |
JUIN TAN, LIANG - Singapore Immunology Network (SIGN), Agency For Science, Technology And Research | |
HARTIMATH, SIDDESH - Singapore Immunology Network (SIGN), Agency For Science, Technology And Research | |
RAMASAMY, BOOMINATHAN - Singapore Immunology Network (SIGN), Agency For Science, Technology And Research | |
CHENG, PETER - Singapore Immunology Network (SIGN), Agency For Science, Technology And Research | |
GROEN, ALBERT - University Of Groningen | |
KUIPERS, FOLKERT - University Of Groningen | |
GOGGI, JULIAN - Singapore Immunology Network (SIGN), Agency For Science, Technology And Research | |
DRUM, CHESTER - National University Of Singapore | |
VAN DAM, ROB - National University Of Singapore | |
SAN TAN, RU - National Heart Centre Singapore | |
RYE, KERRY-ANNE - University Of New South Wales | |
HAYDEN, MICHAEL - University Of British Columbia | |
CHENG, CHING-YU - Singapore National Eye Centre | |
CHACKO, SHAJI - Children'S Nutrition Research Center (CNRC) | |
FLANNICK, JASON - Broad Institute Of Mit/harvard | |
SIM, XUELING - National University Of Singapore | |
CHANG TAN, HONG - Singapore General Hospital | |
SINGARAJA, ROSHNI - National University Of Singapore |
Submitted to: Journal of Clinical Investigation
Publication Type: Peer Reviewed Journal Publication Acceptance Date: 9/8/2022 Publication Date: 11/1/2022 Citation: Zhong, S., Chevre, R., Castano Mayan, D., Corliano, M., Cochran, B.J., Ping Sem, K., Van Dijik, T.H., Peng, J., Juin Tan, L., Hartimath, S.V., Ramasamy, B., Cheng, P., Groen, A.K., Kuipers, F., Goggi, J.L., Drum, C., Van Dam, R.M., San Tan, R., Rye, K., Hayden, M.R., Cheng, C., Chacko, S., Flannick, J., Sim, X., Chang Tan, H., Singaraja, R.R. 2022. Haploinsufficiency of CYP8B1 associates with increased insulin sensitivity in humans. Journal of Clinical Investigation. 132(21). Article e152961. https://doi.org/10.1172/JCI152961. DOI: https://doi.org/10.1172/JCI152961 Interpretive Summary: Bile acids are steroid acids that are synthesized in the liver. There is substantial data linking bile acids to obesity and diabetes risk. Insulin resistance is a condition when cells in muscles, fat, and liver do not respond efficiently to insulin and are unable to easily take up glucose from circulation. Insulin resistance condition has been shown to be associated with increased concentration of certain hydroxylated bile acids. Scientists in Houston, Texas showed that decreased concentration of certain hydroxylated bile acids and concomitant increase in non-hydroxylated bile acids because of some genetic mutations in humans increased insulin sensitivity. This finding proposes a novel target for future therapeutic intervention for diabetes. Technical Abstract: Cytochrome P450 family 8 subfamily B member 1 (CYP8B1) generates 12a-hydroxylated bile acids (BAs) that are associated with insulin resistance in humans. To determine whether reduced CYP8B1 activity improves insulin sensitivity, we sequenced CYP8B1 in individuals without diabetes and identified carriers of complete loss-of-function (CLOF) mutations utilizing functional assays. Mutation carriers had lower plasma 12a-hydroxylated/non–12a-hydroxylated BA and cholic acid (CA)/chenodeoxycholic acid (CDCA) ratios compared with age-, sex-, and BMI-matched controls. During insulin clamps, hepatic glucose production was suppressed to a similar magnitude by insulin, but glucose infusion rates to maintain euglycemia were higher in mutation carriers, indicating increased peripheral insulin sensitivity. Consistently, a polymorphic CLOF CYP8B1 mutation associated with lower fasting insulin in the AMP-T2D-GENES study. Exposure of primary human muscle cells to mutation-carrier CA/CDCA ratios demonstrated increased FOXO1 activity, and upregulation of both insulin signaling and glucose uptake, which were mediated by increased CDCA. Inhibition of FOXO1 attenuated the CDCA-mediated increase in muscle insulin signaling and glucose uptake. We found that reduced CYP8B1 activity associates with increased insulin sensitivity in humans. Our findings suggest that increased circulatory CDCA due to reduced CYP8B1 activity increases skeletal muscle insulin sensitivity, contributing to increased whole-body insulin sensitization. |